Arcus Biosciences, Inc.RCUSNYSE
LOADING
|||
Switch Symbol:
Year-over-year gross profit growth rate
| Period | Value |
|---|---|
| Q3 2025 | -85.00% |
| Q2 2025 | 471.43% |
| Q1 2025 | 7.69% |
| Q4 2024 | -45.83% |
| Q3 2024 | 23.08% |
| Q2 2024 | -73.10% |
| Q1 2024 | 367.74% |
| Q4 2023 | -3.13% |
| Q3 2023 | 10.34% |
| Q2 2023 | 16.00% |
| Q1 2023 | -25.72% |
| Q4 2022 | 1.98% |
| Q3 2022 | 22.22% |
| Q2 2022 | 50.00% |
| Q1 2022 | -94.92% |
| Q4 2021 | 3646.95% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -0.27% |
| Q4 2020 | -85.30% |
| Q3 2020 | 3587.43% |
| Q2 2020 | 0.00% |
| Q1 2020 | -82.05% |
| Q4 2019 | 457.14% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 12.04% |
| Q4 2018 | -63.60% |
| Q3 2018 | 243.28% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 666.87% |
| Q3 2017 | 0.00% |
| Q2 2017 | 0.00% |
| Q1 2017 | 0.00% |